June 26, 2024 Health and Lifestyle 0 Comments Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data [ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed ... Read More
June 24, 2024 Health and Lifestyle 0 Comments Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic [ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk ... Read More
June 18, 2024 Health and Lifestyle 0 Comments Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss [ad_1] Think a friend or colleague should be getting this newsletter? Share this ... Read More
June 17, 2024 Health and Lifestyle 0 Comments How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi [ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide ... Read More
May 30, 2024 Health and Lifestyle 0 Comments Why half of all workers may struggle to get weight-loss drug health insurance coverage [ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed ... Read More
May 29, 2024 Health and Lifestyle 0 Comments Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages [ad_1] GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday ... Read More
May 25, 2024 Health and Lifestyle 0 Comments How digital health companies are capitalizing on the GLP-1 boom [ad_1] Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which ... Read More
May 24, 2024 Health and Lifestyle 0 Comments Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings [ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning ... Read More
May 21, 2024 Health and Lifestyle 0 Comments Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins [ad_1] A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg ... Read More
May 21, 2024 Health and Lifestyle 0 Comments AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era' [ad_1] The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 ... Read More